| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |